Resumen
Background: Histone deacetylases (HDACs) regulate transcriptional responses to injury stimuli that are critical for successful tissue regeneration. Previously we showed that HDAC inhibitor romidepsin potently inhibits axolotl tail regeneration when applied for only 1-minute postamputation (MPA). Results: Here we tested CoCl2, a chemical that induces hypoxia and cellular stress, for potential to reverse romidepsin inhibition of tail regeneration. Partial rescue of regeneration was observed among embryos co-treated with romidepsin and CoCl2 for 1 MPA, however, extending the CoCl2 dosage window either inhibited regeneration (CoCl2:0 to 30 MPA) or was lethal (CoCl2:0 to 24 hours postamputation; HPA). CoCl2:0 to 30 MPA caused tissue damage, tissue loss, and cell death at the distal tail tip, while CoCl2 treatment of non-amputated embryos or CoCl2:60 to 90 MPA treatment after re-epithelialization did not inhibit tail regeneration. CoCl2-romidepsin:1 MPA treatment partially restored expression of transcription factors that are typical of appendage regeneration, while CoCl2:0 to 30 MPA significantly increased expression of genes associated with cell stress and inflammation. Additional experiments showed that CoCl2:0 to 1 MPA and CoCl2:0 to 30 MPA significantly increased levels of glutathione and reactive oxygen species, respectively. Conclusion: Our study identifies a temporal window from tail amputation to re-epithelialization, within which injury activated cells are highly sensitive to CoCl2 perturbation of redox homeostasis.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 852-865 |
| Número de páginas | 14 |
| Publicación | Developmental Dynamics |
| Volumen | 250 |
| N.º | 6 |
| DOI | |
| Estado | Published - jun 2021 |
Nota bibliográfica
Publisher Copyright:© 2021 American Association of Anatomists
Financiación
Preliminary dose-response experiments were performed by undergraduate researchers enrolled in StemCats BIO-199 at University of Kentucky. This research was funded by the National Institutes of Health through their support of this project (R24OD21479), the Ambystoma Genetic Stock Center (P40OD019794), the Center of Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (P20GM130456) and the National Center for Advancing Translational Sciences (UL1TR000117 and UL1TR001998). Preliminary dose‐response experiments were performed by undergraduate researchers enrolled in StemCats BIO‐199 at University of Kentucky. This research was funded by the National Institutes of Health through their support of this project (R24OD21479), the Ambystoma Genetic Stock Center (P40OD019794), the Center of Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (P20GM130456) and the National Center for Advancing Translational Sciences (UL1TR000117 and UL1TR001998).
| Financiadores | Número del financiador |
|---|---|
| Ambystoma Genetic Stock Center | P40OD019794 |
| Center of Biomedical Research Excellence | P20GM130456 |
| National Institutes of Health (NIH) | R24OD21479 |
| National Center for Advancing Translational Sciences (NCATS) | UL1TR001998, UL1TR000117 |
| University of Kentucky |
ASJC Scopus subject areas
- Developmental Biology
Huella
Profundice en los temas de investigación de 'Chemical genetics of regeneration: Contrasting temporal effects of CoCl2 on axolotl tail regeneration'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver